General Bill
Prescription Drug Monitoring Program:
Provides that when controlled substance listed as Schedule II substance is dispensed or released, in addition to other identification procedures, fingerprint may be collected; provides exceptions.
Effective Date:
July 1, 2012
Last Event:
Died in Health & Human Services Quality Subcommittee on Friday, March 9, 2012 11:59 PM
Bill #
|
Subject
|
Relationship
|
Bill #:
SB 1604
|
Subject:
Prescription Drug Monitoring Program
|
Relationship:
Identical
|
(*) Not the latest version